Korys Founded 2001
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 19
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 19
Rounds per year 0.95
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits -
Key employees -
Stages of investment
Late Stage Venture
Private Equity
Seed
Areas of investment
Biotechnology
Finance
Health Care
Information Technology
Medical Device
Renewable Energy
Summary

Korys appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the Huizingen. The venture was found in Europe in Belgium.

We also calculated 8 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Korys, startups are often financed by PMV, Gilde Healthcare, Van Herk Ventures. The meaningful sponsors for the fund in investment in the same round are PMV, Debiopharm Group, Beringea. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, EASME - EU Executive Agency for SMEs.

The higher amount of exits for fund were in 2016. Comparing to the other companies, this Korys performs on 8 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 38 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity.

For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Renewable Energy. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Agendia, Amphivena Therapeutics, Greenbyte AB

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
MyOptique Group
E-Commerce
Retail
Service Industry
Venture - Series Unknown
20M17 Aug 2015 United Kingdom, Westminster
Amphivena Therapeutics
Biotechnology
Health Care
Therapeutics
Series C
62M24 Sep 2019 United States, South San Francisco
MyOptique Group
E-Commerce
Retail
Service Industry
Series C
16M23 Jun 2014 United Kingdom, Westminster
Agendia
Biotechnology
Diagnostic Equipment
Genetics
Health Diagnostics
Life Science
Medical
Other Devices and Supplies
Private Equity
65M31 May 2012 Netherlands, Amsterdam
Eneida
Artificial Intelligence
Clean Energy
Energy Efficiency
Power Grid
Wireless
Series A
5M16 Oct 2020 Portugal, Coimbra
Planet-eco
Renewable Energy
Solar
Venture - Series Unknown
02 Jun 2010 Belgium, Ninove
Greenbyte AB
Renewable Energy
Software
Solar
Wind Energy
Venture - Series Unknown
18 Sep 2017 Sweden, Gothenburg
URBANTZ
Business/Productivity Software
Delivery
Information Technology
Logistics
SaaS
Software
Series A
14M12 Mar 2020 Belgium, City of Brussels
SET Ventures
Finance
Financial Services
Venture Capital
Funding Round
19 Jan 2019 Netherlands, Amsterdam
Genae
Health Care
Medical Device
Venture - Series Unknown
21 Mar 2016 Belgium, Antwerp
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Korys?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: